PDL BioPharma (PDLI) to Offer $250M in Conv Notes
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) intends to offer, subject to market and other conditions, $250 million aggregate principal amount of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
